← Open Payments lookup

DAGOBERTO BALDERAS: Open Payments

NPI 1699835843 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,405 in 146 payments from 30 companies in 2025. Trend: 2023 $3,795 · 2024 $3,594 · 2025 $3,405

Food & beverage: $3,379Education: $27
CompanyPaymentsAmount
Novo Nordisk Inc21$629
Amgen Inc.19$352
AstraZeneca Pharmaceuticals LP17$331
Lilly USA, LLC13$279
ABBVIE INC.10$240
Corcept Therapeutics8$210
Indivior Inc.7$168
PFIZER INC.5$131
TMS NeuroHealth Centers Inc.2$131
Antares Pharma, Inc.5$105

Products named: Rybelsus, Ozempic, Korlym, OTEZLA, VRAYLAR, SUBLOCADE, AIRSUPRA, REPATHA.

Industry payments across TX — which companies pay providers there.